Medical management of mesothelioma

作者: Rayleen Bowman , Vandana Relan , Brett Hughes

DOI: 10.18773/AUSTPRESCR.2011.076

关键词: DiseasePemetrexedMesotheliomaOncologySurgeryInternal medicineRaltitrexedRadical surgeryAntifolateMedicineAsbestosRadiation therapy

摘要: Mesothelioma is a malignant tumour of pleura and other serosal tissues. It arises many years after asbestos exposure. There currently no highly effective therapy the median survival approximately 10-12 months from diagnosis. Most patients cannot be treated surgically due to advanced stage disease at diagnosis or are unfit for radical surgery. New antifolate drugs (pemetrexed raltitrexed) in combination with platinum associated longer than alone, an increase which averages about three months. Radiation limited by its toxicity underlying lung, but newer field dose planning methods under investigation. presents major challenges palliative management dyspnoea, pain, cancer cachexia syndrome.

参考文章(16)
Armando Santoro, Mary E. O'Brien, Rolf A. Stahel, Kristiaan Nackaerts, Paul Baas, Meinolf Karthaus, Wilfried Eberhardt, Luis Paz-Ares, Stein Sundstrom, Yushan Liu, Veronique Ripoche, Johannes Blatter, Carla M. Visseren-Grul, Christian Manegold, Pemetrexed Plus Cisplatin or Pemetrexed Plus Carboplatin for Chemonaïve Patients with Malignant Pleural Mesothelioma: Results of the International Expanded Access Program Journal of Thoracic Oncology. ,vol. 3, pp. 756- 763 ,(2008) , 10.1097/JTO.0B013E31817C73D6
Janet L. Abrahm, Palliative Care for the Patient With Mesothelioma Seminars in Thoracic and Cardiovascular Surgery. ,vol. 21, pp. 164- 171 ,(2009) , 10.1053/J.SEMTCVS.2009.06.006
Martin F Muers, Richard J Stephens, Patricia Fisher, Liz Darlison, Christopher MB Higgs, Erica Lowry, Andrew G Nicholson, Mary O'Brien, Michael Peake, Robin Rudd, Michael Snee, Jeremy Steele, David J Girling, Matthew Nankivell, Cheryl Pugh, Mahesh KB Parmar, Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial The Lancet. ,vol. 371, pp. 1685- 1694 ,(2008) , 10.1016/S0140-6736(08)60727-8
David L. Ball, Deborah G. Cruickshank, The treatment of malignant mesothelioma of the pleura: review of a 5-year experience, with special reference to radiotherapy. American Journal of Clinical Oncology. ,vol. 13, pp. 4- 9 ,(1990) , 10.1097/00000421-199002000-00002
G L Ceresoli, B Castagneto, P A Zucali, A Favaretto, M Mencoboni, F Grossi, D Cortinovis, G Del Conte, A Ceribelli, A Bearz, S Salamina, F De Vincenzo, F Cappuzzo, M Marangolo, V Torri, A Santoro, Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials British Journal of Cancer. ,vol. 99, pp. 51- 56 ,(2008) , 10.1038/SJ.BJC.6604442
Sarita Dubey, Pasi A. Jänne, Lee Krug, Herbert Pang, Xiaofei Wang, Robin Heinze, Colleen Watt, Jeff Crawford, Robert Kratzke, Everett Vokes, Hedy Lee Kindler, A Phase II Study of Sorafenib in Malignant Mesothelioma: Results of Cancer and Leukemia Group B 30307 Journal of Thoracic Oncology. ,vol. 5, pp. 1655- 1661 ,(2010) , 10.1097/JTO.0B013E3181EC18DB
Aneil A. Mujoomdar, Tamara R. Tilleman, William G. Richards, Raphael Bueno, David J. Sugarbaker, Prevalence of in vitro chemotherapeutic drug resistance in primary malignant pleural mesothelioma: Result in a cohort of 203 resection specimens The Journal of Thoracic and Cardiovascular Surgery. ,vol. 140, pp. 352- 355 ,(2010) , 10.1016/J.JTCVS.2009.11.072
Pasi A. Jänne, Chemotherapy for malignant pleural mesothelioma. Clinical Lung Cancer. ,vol. 5, pp. 98- 106 ,(2003) , 10.3816/CLC.2003.N.023
Martin Reck, Rolf A. Stahel, Joachim von Pawel, Meinolf Karthaus, Soenke Korfee, Monika Serke, Wolfgang H.-W. Schuette, Corinna Eschbach, Thomas H. Fink, Monika I. Leschinger, Christian Manegold, Pemetrexed in the treatment of malignant mesothelioma: results from an expanded access program in Germany. Respiratory Medicine. ,vol. 104, pp. 142- 148 ,(2010) , 10.1016/J.RMED.2009.07.019
Nicholas J. Vogelzang, James J. Rusthoven, James Symanowski, Claude Denham, E. Kaukel, Pierre Ruffie, Ulrich Gatzemeier, Michael Boyer, Salih Emri, Christian Manegold, Clet Niyikiza, Paolo Paoletti, Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma Journal of Clinical Oncology. ,vol. 21, pp. 2636- 2644 ,(2003) , 10.1200/JCO.2003.11.136